Peptide guide

MOTS-c

A mitochondrial-derived peptide studied for metabolism, insulin sensitivity, and exercise capacity — often called an "exercise mimetic."

MOTS-c is a 16-amino-acid peptide your own mitochondria make, marketed by anti-aging and weight-loss clinics as "exercise in a vial." The science behind it is real but almost entirely from animals and cell cultures: it activates AMPK, the body's main metabolic switch, and improves insulin sensitivity and endurance in mice. It isn't FDA-approved, the injectable peptide has no completed human efficacy trials, and the closest thing to human data came from a MOTS-c analog whose development was shelved. People still run it for metabolic and energy goals, so the practical questions are how to handle it and how to avoid getting scammed buying it.

Type
16-aa peptideMitochondrial-derived
Route
Subcutaneous
Typical dose
~5 mg 2–3×/wkor 200mcg–1mg daily
Cycle
4–8 wks onweeks, not forever
Storage
Mixed: ~weeksSealed: months frozen
Status
Not FDA-approved

What is MOTS-c?

A 16-amino-acid peptide your own mitochondria make, sold as a synthetic copy and first characterized in 2015 — not FDA-approved and with no completed human efficacy trial.

MOTS-c is a peptide, a short chain of amino acids, sixteen of them in this case. What sets it apart from most peptides sold online is where it comes from. It isn't encoded in your main genome the way nearly every other protein is. It's written into the small, separate strip of DNA inside your mitochondria, the structures that turn food and oxygen into usable energy. The name stands for Mitochondrial Open Reading Frame of the 12S rRNA-c, which is just the spot in that mitochondrial DNA where the sequence sits.

That origin is the whole reason people find it interesting. Your body already makes MOTS-c, and the amount in your muscle jumps sharply during exercise. Researchers found roughly a twelve-fold rise in skeletal muscle after acute exertion, which is why it gets called an exercise mimetic. The version sold in vials is a synthetic copy of that natural sequence, built in a lab. It's the same molecule your mitochondria produce, manufactured and injected rather than made on demand.

It belongs to a young class of molecules called mitochondrial-derived peptides, with MOTS-c itself first characterized in 2015. That's worth keeping in mind. This isn't a compound with decades of human use behind it; it's a recent discovery that moved from the lab to clinic marketing faster than the human evidence did.

MOTS-c isn't FDA-approved for anything. The injectable peptide has no completed human efficacy trials, and nearly everything known about its effects comes from animal and cell-culture studies. Treat it as an experimental research compound, not a proven medicine.

What is it studied for?

Almost all research is in mice and cell cultures; the closest human data is from an analog, CB4211, taken through an early Phase 1 study before the program was shelved.

Almost all of this research was done in animals, mostly mice, and in cell cultures. The marketed peptide itself has never completed a published human efficacy trial. The closest the field has come is an engineered MOTS-c analog called CB4211, which a company took through an early Phase 1 safety study before shelving the program. So "studied for" mostly means "studied for in mice and in dishes," and that distinction sits under every claim below.

Evidence base, by subject
ManyAnimal & cell-culture studies
NoneHuman trials of the peptide

The research has clustered in a few areas:

Metabolism & body weightIn diet-induced obese mice, MOTS-c reduced fat accumulation and improved metabolic markers. This is the basis for the weight-loss marketing.
Insulin sensitivityMouse studies report meaningfully better whole-body insulin response, with more glucose taken up by muscle through the GLUT4 transporter.
Exercise capacity & agingIn animals it improved endurance and helped preserve muscle with age, the findings behind the "exercise mimetic" label.

The mechanism is better understood than for most peptides in this category. MOTS-c acts largely through AMPK, the enzyme that works as the body's master fuel gauge: when energy runs low, AMPK switches cells toward burning fuel and taking up glucose. MOTS-c also moves into the cell nucleus under metabolic stress and helps switch on protective, antioxidant genes. What stays open is whether an injected dose reliably reproduces in a living human what's been mapped in mice and in cell lines, and how much of the natural signal a once-or-twice-weekly shot can stand in for.

Why people use it

People reach for it for fat loss, blood sugar, and the "exercise in a vial" pitch, but no human trial shows the peptide delivers any of it.

Most people who try MOTS-c are chasing a metabolic goal rather than an injury. These are the reasons they reach for it, not evidence that it delivers:

  • Stubborn fat loss or a stalled metabolism, drawn in by the obesity and body-composition work in mice.
  • Blood-sugar and insulin concerns, where the animal data on glucose handling is the strongest part of the story.
  • Wanting the metabolic upside of training when they can't train as much as they'd like, the "exercise in a vial" pitch.
  • Longevity and healthy-aging interest, since MOTS-c levels fall with age and the peptide preserved muscle and endurance in older animals.
No human trial has shown the MOTS-c peptide will do any of this. What's there is an unusually clear mechanism through AMPK, a consistent metabolic signal across animal studies, and one early-phase human safety study of a close analog that was well tolerated and nudged liver enzymes and fasting glucose in the right direction before the program was dropped. It's worth being curious about. It isn't enough to rely on, and it won't replace the things that genuinely move metabolism and insulin sensitivity: actual training, sleep, protein, and managing body weight.

How to reconstitute MOTS-c

Mix a 10 mg vial with 2 mL bacteriostatic water for 5 mg/mL, so 50 units on a U-100 syringe is 2.5 mg and 100 units is a full 5 mg.

Your vial arrives as a small puck of dry powder. Before you can use it, you mix it into a liquid. That step is called reconstitution, and it's the same process used for most research peptides.

Step 1Start with powderWipe the rubber stopper with an alcohol swab.
Step 2Add bac. waterRun it slowly down the inside wall — never shake.
Step 3Draw your doseThe calculator gives the exact units to draw to.
  • Wipe the rubber stopper with an alcohol swab first, every time.
  • Use bacteriostatic water, not plain sterile water and not saline. The trace of benzyl alcohol in it holds back bacteria, which matters because you'll be drawing from the same vial across a course of injections.
  • Add the water slowly, running it down the inside glass wall. Don't blast it straight onto the powder.
  • Don't shake it. Swirl gently and let it dissolve on its own. Shaking foams the solution and can damage the peptide.

A common setup is a 10 mg vial mixed with 2 mL of bacteriostatic water, which gives 5 mg/mL. On a U-100 insulin syringe, 50 units is then 2.5 mg and 100 units is a full 5 mg. The water doesn't change how much peptide is in the vial; it only sets the concentration, which decides how many units you draw. More water means a more dilute mix and a bigger draw for the same dose. You can't ruin it with too much or too little, you only change the draw math, and that's exactly what the calculator handles.

Calculate your exact MOTS-c reconstitution →

Dose & units

No dose is FDA-approved; sources report either about 5 mg two-to-three times weekly or 200 mcg–1 mg daily, typically 4–8 weeks on then several weeks off.

There is no FDA-approved dose for MOTS-c. Everything below is a range that clinics and write-ups report, not a medical standard, and the sources disagree enough that no single "right" protocol exists. Decide what goes into your body with a licensed provider, not with this page.

Typical range

Two reporting conventions circulate, and they don't map cleanly onto each other. The more common one is a few milligrams per dose, often around 5 mg given two to three times a week. The other is a smaller daily approach, roughly 200 mcg to 1 mg once a day, titrated up over weeks. Both are subcutaneous, into the fat of the abdomen, thigh, or upper arm.

Titration

Most write-ups start at the low end, whether that's 5 mg twice a week or 200 mcg daily, and step up only after a couple of weeks. Starting low lets you notice any reaction, and given the reported palpitations and sleep effects, that caution earns its keep.

Cycling

Sources treat this as a time-limited course rather than something to run indefinitely, commonly 4 to 8 weeks on followed by several weeks off. The wide spread across sources is itself a signal of how soft these numbers are.

On4–8 weeks
Offseveral weeks

For the exact mark to draw to on your insulin syringe, don't eyeball it. The calculator turns your vial size, water, and dose into the precise number of units.

Get your exact units →

Storage

Sealed powder keeps for months; once mixed, refrigerate at 2–8 °C and use within a few weeks, since quoted windows run only one week to a month.

Sealed & drySealed dry powder stays stable for months and travels well; keep lyophilized MOTS-c frozen for long-term storage.
ReconstitutedRefrigerate at 2–8 °C in the main compartment, use within a few weeks; don't freeze, keep out of light, and toss if cloudy.
You'll see windows from one week up to a month quoted for a mixed MOTS-c vial, which is shorter and more variable than what's claimed for sturdier peptides. Those figures are about how long the preservative in bacteriostatic water reliably keeps the solution clean once you're drawing from it, and how long the peptide holds its potency in liquid. When sources disagree, the conservative end is the safer bet.

That limit is mostly about contamination, not potency, though MOTS-c in solution is also less robust than some peptides, so the two reasons to respect the window line up here. Reconstitute with plain sterile water instead of bacteriostatic and you drop to a day or two, since there's no preservative holding bacteria back.

Don't freeze a reconstituted vial, keep it out of direct light, write the mix date on the label, and throw it out if the solution ever turns cloudy or discolored, whatever the date says.

Side effects & safety

Reported effects are mild — injection-site irritation, palpitations, sleep trouble — but data is thin, low blood sugar is plausible, and MOTS-c is WADA-banned at all times with no TUE possible.

The reported side effects are generally mild, but the picture is thin. It comes from animal studies, one early-phase trial of an analog, and scattered self-experimenter reports, not large human safety trials, so hold it loosely.

  • Most common: mild, short-lived redness or irritation at the injection site.
  • Reported by self-experimenters: a faster heart rate or palpitations, trouble sleeping, and occasionally a brief fever or flu-like feeling.
  • Because it pushes the body toward burning fuel and taking up glucose, low blood sugar is a plausible concern, especially for anyone already on glucose-lowering medication.
No formal toxicology, drug-interaction, or long-term human safety studies exist for MOTS-c, and no published human trial runs past about twelve weeks. If you're diabetic or on any blood-sugar medication, the glucose-lowering effect could stack dangerously with what you already take. Talk to a doctor before starting, and the same goes if you're pregnant, breastfeeding, or managing a serious health condition.

If you compete, MOTS-c is banned at all times under the WADA Prohibited List, listed by name as an AMPK activator under metabolic modulators (S4.4.1). Because it has no approved therapeutic use, an athlete can't even obtain a therapeutic use exemption for it. A positive test is a doping violation.

And the biggest risk here isn't really the molecule. It's whether what's in the vial is actually MOTS-c, at the strength on the label. That comes down to where you buy it.

How to vet a source

Get the batch-specific COA from a third-party lab before buying, match the lot number to your vial, and never accept a screenshot in place of a traceable report.

This is an unregulated market, and a real share of independently tested vials come back underdosed, impure, or not even the compound on the label. MOTS-c is heavily promoted by wellness clinics and social media as a weight-loss shortcut, exactly the kind of hype that draws low-quality sellers, and the FDA has flagged that compounded peptides like this can carry impurity and immune-reaction risks. You can't see any of that in the powder. The one document that separates a real seller from a gamble is a certificate of analysis: a third-party lab's report on what's actually in the vial.

A real COA shows
  • An identity test (usually mass spectrometry) confirming the peptide is what the label says.
  • A purity figure from HPLC, typically 98% or higher.
  • A lot or batch number that matches the number printed on your vial.
  • A named, independent accredited lab and a recent test date.
Walk away if
  • There’s no COA, or it’s a generic image with no lot number.
  • The “certificate” comes from the seller instead of a third-party lab.
  • The lot number doesn’t match your vial, or there isn’t one at all.
  • It’s a flat image you can’t trace back to the lab that issued it.

That's the standard worth holding any seller to, ours included. Ask for the batch-specific COA before you buy, match the lot number to your vial, and don't accept a screenshot in place of a traceable report.

See the Zapify compound catalog →

Common questions about MOTS-c

Is MOTS-c approved or proven to work in people?
No. It isn't FDA-approved for any use, and the injectable peptide has no completed human efficacy trials. Nearly all the evidence is from mice and cell cultures. The one human signal comes from CB4211, an engineered MOTS-c analog that passed an early Phase 1 safety study, showing modest drops in liver enzymes and fasting glucose, before its development was discontinued. That's encouraging for the concept, not proof the peptide works.
Why is MOTS-c called an "exercise mimetic"?
Because your body makes it during exertion. MOTS-c levels in skeletal muscle rise roughly twelve-fold after acute exercise, and it works through AMPK, the same metabolic switch that exercise flips. In animals, giving it improved endurance and metabolism. The marketing leap to "exercise in a vial" runs well ahead of the human evidence, which doesn't yet exist for the injected peptide.
How is MOTS-c dosed, in milligrams or micrograms?
Both conventions are out there, which tells you how unsettled this is. The more common one is a few milligrams per dose, often around 5 mg two to three times a week. The other is a smaller daily approach, roughly 200 mcg to 1 mg once a day, titrated up. They don't map neatly onto each other, so don't assume a number you saw in one protocol applies to the other. A licensed provider, not a forum post, should set what you actually use.
Can MOTS-c affect my blood sugar?
Plausibly, yes. Its main mechanism pushes cells to take up glucose and burn fuel, which is the whole point for metabolic goals, but it also means it could lower blood sugar. If you're diabetic or on any glucose-lowering medication, that effect could stack with what you already take. This is a conversation to have with a doctor before starting, not something to test on yourself.
Why bacteriostatic water and not saline or sterile water?
Because you'll be drawing from the same vial across a course of injections. Bacteriostatic water carries a trace of benzyl alcohol that holds back bacteria between draws; plain sterile water and saline have no preservative. On a multi-dose peptide vial, the professional sources all point the same way: bacteriostatic.

References

  1. Lee C, Zeng J, et al. — The Mitochondrial-Derived Peptide MOTS-c Promotes Metabolic Homeostasis and Reduces Obesity and Insulin Resistance (Cell Metabolism, 2015)
  2. Kim KH, et al. — The mitochondrial-derived peptide MOTS-c is a regulator of plasma metabolites and enhances insulin sensitivity (Physiological Reports, 2019)
  3. Reynolds JC, et al. — MOTS-c is an exercise-induced mitochondrial-encoded regulator of age-dependent physical decline and muscle homeostasis (Nature Communications, 2021)
  4. MOTS-c: A promising mitochondrial-derived peptide for therapeutic exploitation (review, Frontiers in Endocrinology / PMC, 2023)
  5. USADA — What is the MOTS-c peptide? (anti-doping status and reported side effects)
  6. WADA — The Prohibited List (S4.4.1 AMPK activators, MOTS-c named)
  7. CohBar — Positive Topline Results from the Phase 1a/1b Study of CB4211, a MOTS-c analog, for NASH and Obesity (2021)
  8. Innerbody Research — MOTS-c Peptide: Benefits, Safety & Buying Advice (2026)
  9. Frontiers in Physiology — Mitochondria-derived peptide MOTS-c restores mitochondrial respiration in the type 2 diabetic heart (2025)
  10. Peptide Dosing Protocols — MOTS-c Dosing Guide: Protocol, Reconstitution & Metabolism (2026)
This page is for research and educational purposes only. It is not medical advice or a recommendation to use any compound. The dose ranges shown are reported by clinics and research literature, not validated medical standards, and MOTS-c is not FDA-approved. Talk to a licensed medical provider about anything you put in your body.